XML 35 R13.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Earnings Per Share | 12 Months Ended
--- | ---
Dec. 31, 2024
Earnings Per Share [Abstract] |
Earnings Per Share | Note 6 Earnings Per Share Basic earnings (loss) per share attributable to UScellular shareholders is computed by dividing Net income (loss) attributable to UScellular shareholders by the weighted average number of Common Shares outstanding during the period. Diluted earnings (loss) per share attributable to UScellular shareholders is computed by dividing Net income (loss) attributable to UScellular shareholders by the weighted average number of Common Shares outstanding during the period adjusted to include the effects of potentially dilutive securities. Potentially dilutive securities primarily include incremental shares issuable upon the exercise of outstanding stock options and the vesting of performance and restricted stock units, as calculated using the treasury stock method. The amounts used in computing basic and diluted earnings (loss) per share attributable to UScellular shareholders were as follows:
Year Ended December 31, | 2024 |  | 2023 |  | 2022
(Dollars and shares in millions, except per share amounts) |  |  |  |  |
Net income (loss) attributable to UScellular shareholders | $ | (39) |  |  | $ | 54 |  |  | $ | 30 |
Weighted average number of shares used in basic earnings (loss) per share | 86 |  |  | 85 |  |  | 85 |
Effects of dilutive securities | — |  |  | 2 |  |  | 1 |
Weighted average number of shares used in diluted earnings (loss) per share | 86 |  |  | 87 |  |  | 86 |
Basic earnings (loss) per share attributable to UScellular shareholders | $ | (0.46) |  |  | $ | 0.64 |  |  | $ | 0.35 |
Diluted earnings (loss) per share attributable to UScellular shareholders | $ | (0.46) |  |  | $ | 0.63 |  |  | $ | 0.35 |
Certain Common Shares issuable upon the exercise of stock options or vesting of performance and restricted stock units were not included in weighted average diluted shares outstanding for the calculation of Diluted earnings (loss) per share attributable to UScellular shareholders because their effects were antidilutive. The number of such Common Shares excluded was 3 million,1 million and less than 1 million in 2024, 2023 and 2022, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration